Clinical trial
Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy
NCT00104338 · Astellas Pharma Inc, Industry · Terminated
Key facts
| NCT number | NCT00104338 |
|---|---|
| Title | Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy |
| Official title | A Phase 2, Proof of Concept, Randomized, Open-label, Two-arm, Parallel Group, Multi-center Study to Assess the Efficacy and Safety of FK778 Compared With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | BK Polyomavirus, Kidney Diseases |
| Intervention type | Drug |
| Interventions | FK778 |
| Enrollment | 45 |
| Start date | Jan 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Feb 25, 2005 |
| Last update posted | Jun 7, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: